Revisiting HBV resistance to entecavir with a phenotypic approach-Reference-Cited by-同舟云学术

Revisiting HBV resistance to entecavir with a phenotypic approach

Published:2020-09 Issue: Volume:181 Page:104869
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Marlet Julien,Lier Clément,Roch Emmanuelle,Maugey Morgan,Moreau Alain,Combe Benjamin,Lefeuvre Sandrine,d’Alteroche Louis,Barbereau Didier,Causse Xavier,Bastides Frédéric,Bachelier Marie-Nadege,Brand Denys,Gaudy-Graffin Catherine

Funder

Thellie endowment fund

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference34 articles.

1. Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response;Baldick;J. Hepatol.,2008

2. Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance;Baldick;Hepatology,2008

3. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity;Blanchet;J. Virol.,2006

4. Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir;Brunelle;Hepatology,2005

5. A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients;Chang;Gastroenterology,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traitement de l’hépatite B chronique par ténofovir : aspects virologiques et pharmacologiques;Virologie;2022-05-01

2. Evolution and phenotypic characterization of whole HBV genome in compliant patients experiencing unexplained entecavir treatment failure;Antiviral Research;2021-08

3. Synthesis and Antiviral Evaluation of (1,4-Disubstituted-1,2,3-Triazol)-(E)-2-Methyl-but-2-Enyl Nucleoside Phosphonate Prodrugs;Molecules;2021-03-09